PFM Health Sciences’s TSMC TSM Stock Holding History

PFM Health Sciences’s Portfolio TSM Stock Details TSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,437,247	Closed	-$63.5M	–	124
2018 Q3	$63.5M	Buy	+1,437,247	New	+$59.5M	0.93%	44

Other funds holding TSM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PFM Health Sciences's TSM Position: Q4 2018 in Review

PFM Health Sciences sold out of TSMC (TSM) in Q4 2018, closing a stake of 1,437,247 shares — an estimated $63.5M sold.

PFM Health Sciences first reported a position in TSM in Q3 2018 and held it in 1 quarter. The position peaked at $63.5M in Q3 2018. 754 funds tracked by Wall St. Rank hold TSM as of Q4 2018.

PFM Health Sciences reported no remaining TSMC position as of Q4 2018 after selling out during the quarter.
PFM Health Sciences sold 1,437,247 TSMC shares in Q4 2018, an estimated $63.5M.
PFM Health Sciences first reported a position in TSMC in Q3 2018 and held it in 1 quarter.
PFM Health Sciences's TSMC position peaked at $63.5M in Q3 2018.
754 funds tracked by Wall St. Rank held TSMC as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.